Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Marcu, R. Christian, Darryl Lau, Anne Zielinski, M. Horowitz, J. Lee, Arash Pakdel, J. Allison, Chandani Limbad, D. Moore, G. Yount, P. Desprez, S. McAllister (2010)
Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and SurvivalMolecular Cancer Therapeutics, 9
S. McAllister, R. Murase, R. Christian, Darryl Lau, Anne Zielinski, J. Allison, C. Almanza, Arash Pakdel, J. Lee, Chandani Limbad, Yong Liu, R. Debs, Dan Moore, P. Desprez (2011)
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasisBreast Cancer Research and Treatment, 129
L. Timmerman, T. Holton, M. Yuneva, R. Louie, M. Padró, A. Daemen, Min Hu, D. Chan, S. Ethier, L. Veer, K. Polyak, F. McCormick, J. Gray (2013)
Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target.Cancer cell, 24 4
R. Pertwee (1997)
Pharmacology of cannabinoid CB1 and CB2 receptors.Pharmacology & therapeutics, 74 2
S. Sarfaraz, F. Afaq, V. Adhami, A. Malik, H. Mukhtar (2006)
Cannabinoid Receptor Agonist-induced Apoptosis of Human Prostate Cancer Cells LNCaP Proceeds through Sustained Activation of ERK1/2 Leading to G1 Cell Cycle Arrest*Journal of Biological Chemistry, 281
Xinbing Sui, R. Chen, Z. Wang, Zehuan Huang, Na Kong, M. Zhang, W. Han, F. Lou, J. Yang, Qiang Zhang, Xian Wang, Chao He, H. Pan (2013)
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatmentCell Death & Disease, 4
S. McAllister, R. Christian, M. Horowitz, Amaia Garcia, P. Desprez (2007)
Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cellsMolecular Cancer Therapeutics, 6
S. Mato, María Sánchez-Gómez, C. Matute (2010)
Cannabidiol induces intracellular calcium elevation and cytotoxicity in oligodendrocytesGlia, 58
T. Klein (2005)
Cannabinoid-based drugs as anti-inflammatory therapeuticsNature Reviews Immunology, 5
J. Armstrong, D. Hill, Christopher McKee, S. Hernández‐Tiedra, M. Lorente, I. López‐Valero, Maria Anagnostou, Fiyinfoluwa Babatunde, M. Corazzari, C. Redfern, G. Velasco, P. Lovat (2015)
Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death.The Journal of investigative dermatology, 135 6
Allyn Howlett (1987)
Cannabinoid inhibition of adenylate cyclase: Relative activity of constituents and metabolites of marihuanaNeuropharmacology, 26
T. Sugiura, S. Kondo, A. Sukagawa, S. Nakane, A. Shinoda, K. Itoh, A. Yamashita, K. Waku (1995)
2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.Biochemical and biophysical research communications, 215 1
G. Velasco, I. Galve-Roperh, C. Sánchez, C. Blázquez, M. Guzmán (2004)
Hypothesis: cannabinoid therapy for the treatment of gliomas?Neuropharmacology, 47
Anju Preet, Zahida Qamri, M. Nasser, A. Prasad, K. Shilo, X. Zou, J. Groopman, R. Ganju (2010)
Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non–Small Cell Lung Cancer Growth and MetastasisCancer Prevention Research, 4
A. Hampson, M. Grimaldi, J. Axelrod, D. Wink (1998)
Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.Proceedings of the National Academy of Sciences of the United States of America, 95 14
T Sugiura, S Kondo, A Sukagawa, S Nakane, A Shinoda, K Itoh, A Yamashita, K Waku (1995)
2-Arachidonoylglycerol: a possible cannabinoid receptor ligand in the brainBiochem Biophys Res Commun, 215
M. Ponz-Sarvisé, P. Nguewa, M. Pajares, J. Agorreta, M. Lozano, M. Redrado, R. Pio, C. Behrens, I. Wistuba, C. Garcia-Franco, J. García-Foncillas, L. Montuenga, A. Calvo, I. Gil-Bazo (2011)
Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy ResistanceClinical Cancer Research, 17
S. Jacobsson, Eva Rongård, Maria Stridh, G. Tiger, C. Fowler (2000)
Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability.Biochemical pharmacology, 60 12
P. Massi, A. Vaccani, Silvia Bianchessi, B. Costa, P. Macchi, D. Parolaro (2006)
The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cellsCellular and Molecular Life Sciences CMLS, 63
M. Pérez-Reyes, M. Timmons, K. Davis, E. Wall (1973)
A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol.Experientia, 29 11
A. Swarbrick, Emie Roy, Thaddeus Allen, J. Bishop (2008)
Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence responseProceedings of the National Academy of Sciences, 105
S. Cardaci, G. Filomeni, M. Ciriolo (2012)
Redox implications of AMPK-mediated signal transduction beyond energetic cluesJournal of Cell Science, 125
K. Scott, A. Dalgleish, Wai Liu (2014)
The Combination of Cannabidiol and Δ9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma ModelMolecular Cancer Therapeutics, 13
T. Järbe, A. Hiltunen (1987)
Cannabimimetic activity of cannabinol in rats and pigeonsNeuropharmacology, 26
Sofía Torres, M. Lorente, Fátima Rodríguez-Fornés, S. Hernández‐Tiedra, M. Salazar, E. García‐Taboada, J. Barcia, M. Guzmán, G. Velasco (2011)
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against GliomaMolecular Cancer Therapeutics, 10
Alexis Laurent, C. Nicco, C. Chéreau, C. Goulvestre, J. Alexandre, A. Alvès, E. Lévy, F. Goldwasser, Y. Panis, O. Soubrane, B. Weill, F. Batteux (2005)
Controlling tumor growth by modulating endogenous production of reactive oxygen species.Cancer research, 65 3
A. Hiltunen, T. Järbe, M. Kamkar, T. Archer (1989)
Behaviour in rats maintained by low differential reinforcement rate: Effects of Δ1-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinationNeuropharmacology, 28
A. Ohlsson, J. Lindgren, A. Wahlén, S. Agurell, L. Hollister, H. Gillespie (1980)
Plasma delta‐9‐tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smokingClinical Pharmacology & Therapeutics, 28
J. Flygare, B. Sander (2008)
The endocannabinoid system in cancer-potential therapeutic target?Seminars in cancer biology, 18 3
Marta Solinas, Paola Massi, A. Cantelmo, M. Cattaneo, R. Cammarota, Desirée Bartolini, Valentina Cinquina, M. Valenti, L. Vicentini, D. Noonan, Adriana Albini, D. Parolaro (2012)
Cannabidiol inhibits angiogenesis by multiple mechanismsBritish Journal of Pharmacology, 167
Ashutosh Shrivastava, P. Kuzontkoski, J. Groopman, A. Prasad (2011)
Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and AutophagyMolecular Cancer Therapeutics, 10
J. McPartland, Ethan Russo (2001)
Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts?, 1
R. Ramer, Katharina Bublitz, Nadine Freimuth, J. Merkord, Helga Rohde, Maria Haustein, Philipp Borchert, Ellen Schmuhl, M. Linnebacher, B. Hinz (2012)
Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule‐1The FASEB Journal, 26
H Edery, Y Grunfeld, Z Ben-Zvi, R Mechoulam (1971)
Structural requirements for cannabinoid activityAnn NY Acad Sci, 191
S. Turkanis, R. Karler (1975)
Influence of anticonvulsant cannabinoids on posttetanic potentiation at isolated bullfrog ganglia.Life sciences, 17 4
R. Karler, S. Turkanis (1978)
Cannabis and epilepsy.Advances in the biosciences, 22-23
N. Kogan, R. Rabinowitz, P. Levi, D. Gibson, P. Sándor, M. Schlesinger, R. Mechoulam (2004)
Synthesis and antitumor activity of quinonoid derivatives of cannabinoids.Journal of medicinal chemistry, 47 15
A. Malfait, R. Gallily, P. Sumariwalla, A. Malik, E. Andreakos, R. Mechoulam, M. Feldmann (2000)
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.Proceedings of the National Academy of Sciences of the United States of America, 97 17
G. Gupta, Jonathan Perk, Swarnali Acharyya, P. Candia, V. Mittal, Katia Todorova-Manova, W. Gerald, E. Brogi, R. Benezra, J. Massagué (2007)
ID genes mediate tumor reinitiation during breast cancer lung metastasisProceedings of the National Academy of Sciences, 104
Momoko Yoshikawa, K. Tsuchihashi, T. Ishimoto, Toshifumi Yae, T. Motohara, E. Sugihara, N. Onishi, T. Masuko, K. Yoshizawa, S. Kawashiri, M. Mukai, S. Asoda, H. Kawana, T. Nakagawa, H. Saya, O. Nagano (2013)
xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma.Cancer research, 73 6
C. Turner, M. Elsohly, E. Boeren (1980)
Constituents of Cannabis sativa L. XVII. A review of the natural constituents.Journal of natural products, 43 2
S. Alozie, B. Martin, L. Harris, W. Dewey (1980)
3H-Δ9-tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: Penetration and regional distribution in rat brainPharmacology Biochemistry and Behavior, 12
R. Ramer, K. Heinemann, J. Merkord, Helga Rohde, A. Salamon, M. Linnebacher, B. Hinz (2012)
COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer CellsMolecular Cancer Therapeutics, 12
C. Hunt, Reese Jones, R. Herning, J. Bachman (1981)
Evidence that cannabidiol does not significantly alter the pharmacokinetics of tetrahydrocannabinol in manJournal of Pharmacokinetics and Biopharmaceutics, 9
W. Davis, N. Hatoum (1983)
Neurobehavioral actions of cannabichromene and interactions with delta 9-tetrahydrocannabinol.General pharmacology, 14 2
A. Zuardi (2008)
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.Revista brasileira de psiquiatria, 30 3
G. Velasco, C. Sánchez, M. Guzmán (2012)
Towards the use of cannabinoids as antitumour agentsNature Reviews Cancer, 12
M. Donadelli, I. Dando, T. Zaniboni, C. Costanzo, E. Pozza, M. Scupoli, Aldo Scarpa, S. Zappavigna, M. Marra, A. Abbruzzese, Maurizio Bifulco, Michele Caraglia, M. Palmieri (2011)
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanismCell Death & Disease, 2
Ping Mao, Kaushal Joshi, Jianfeng Li, Sung-Hak Kim, Pei-pei Li, L. Santana-Santos, Soumya Luthra, U. Chandran, P. Benos, L. Smith, Maode Wang, Bo Hu, Shi-Yuan Cheng, R. Sobol, I. Nakano (2013)
Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3Proceedings of the National Academy of Sciences, 110
A. Vaccani, P. Massi, A. Colombo, T. Rubino, D. Parolaro (2005)
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor‐independent mechanismBritish Journal of Pharmacology, 144
W. Dalton, R. Martz, L. Lemberger, B. Rodda, R. Forney (1976)
Influence of cannabidiol on delta‐9‐tetrahydrocannabinol effectsClinical Pharmacology & Therapeutics, 19
S. Fong, Y. Itahana, T. Sumida, Jarnail Singh, Jean-Philippe Coppé, Yong Liu, P. Richards, J. Bennington, N. Lee, R. Debs, P. Desprez (2003)
Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasisProceedings of the National Academy of Sciences of the United States of America, 100
F. Guimarães, J. Aguiar, R. Mechoulam, A. Breuer (1994)
Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.General pharmacology, 25 1
A. Carracedo, M. Gironella, M. Lorente, S. Garcia, M. Guzmán, G. Velasco, J. Iovanna (2006)
Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes.Cancer research, 66 13
A. Minn, G. Gupta, P. Siegel, Paula Bos, Weiping Shu, D. Giri, A. Viale, A. Olshen, W. Gerald, J. Massagué (2005)
Genes that mediate breast cancer metastasis to lungNature, 436
K. Brady, R. Balster (2004)
The effects of Δ9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeysPsychopharmacology, 72
R Mechoulam, S Ben-Shabat, S Hanus, M Ligumsky, NE Kaminski, AR Schatz, A Gopher, S Almong, BR Martin, DR Compton, RG Pertwee, G Griffin, M Bayewitch, J Barg, Z Vogel (1995)
Identification of a 2-mono-glyceride, present in canine gut, that biinds to cannabinoid receptorsBiochem Pharmacol, 50
W. Davis, N. Hatoum (1983)
Neurobehavioral actions of cannabichromene and interactions with Δ9-tetrahydrocannabinolGeneral Pharmacology-the Vascular System, 14
R. Ramer, B. Hinz (2008)
Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.Journal of the National Cancer Institute, 100 1
M. Bifulco, V. Marzo (2002)
Targeting the endocannabinoid system in cancer therapy: A call for further researchNature Medicine, 8
P. Massi, A. Vaccani, S. Ceruti, A. Colombo, M. Abbracchio, D. Parolaro (2004)
Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell LinesJournal of Pharmacology and Experimental Therapeutics, 308
S. Agurell, S. Carlsson, J. Lindgren, A. Ohlsson, H. Gillespie, L. Hollister (1981)
Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography.Experientia, 37 10
I. Dando, M. Donadelli, C. Costanzo, E. Pozza, A. D’Alessandro, L. Zolla, M. Palmieri (2013)
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cellsCell Death & Disease, 4
W. Jaeger, Leslie Benet, L. Bornheim (1996)
Inhibition of cyclosporine and tetrahydrocannabinol metabolism by cannabidiol in mouse and human microsomes.Xenobiotica; the fate of foreign compounds in biological systems, 26 3
Hao‐Jie Zhu, Jun-sheng Wang, John Markowitz, J. Donovan, Bryan Gibson, H. Gefroh, C. Devane (2006)
Characterization of P-glycoprotein Inhibition by Major Cannabinoids from MarijuanaJournal of Pharmacology and Experimental Therapeutics, 317
Mohamad Elbaz, M. Nasser, J. Ravi, N. Wani, D. Ahirwar, Helong Zhao, S. Oghumu, A. Satoskar, K. Shilo, W. Carson, R. Ganju (2015)
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti‐tumor mechanisms of Cannabidiol in breast cancerMolecular Oncology, 9
Joyce Baldwin (1994)
Structure and function of receptors coupled to G proteins.Current opinion in cell biology, 6 2
R. Murase, Rumi Kawamura, Eric Singer, Arash Pakdel, P. Sarma, Jonathon Judkins, Eiman Elwakeel, Sonali Dayal, Esther Martinez-Martinez, Mukkanti Amere, R. Gujjar, A. Mahadevan, P. Desprez, S. McAllister (2014)
Targeting multiple cannabinoid anti‐tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancerBritish Journal of Pharmacology, 171
L. Hollister, H. Gillespie (1975)
Interactions in man of delta‐9‐tetrahydrocannabinol; II. Cannabinol and cannabidiolClinical Pharmacology & Therapeutics, 18
S. Ward, S. McAllister, Rumi Kawamura, Ryuchi Murase, H. Neelakantan, E. Walker (2014)
Cannabidiol inhibits paclitaxel‐induced neuropathic pain through 5‐HT1A receptors without diminishing nervous system function or chemotherapy efficacyBritish Journal of Pharmacology, 171
A. Hiltunen, T. Järbe, Kerstin Wängdahl (1988)
Cannabinol and cannabidiol in combination: Temperature, open-field activity, and vocalizationPharmacology Biochemistry and Behavior, 30
M. Elsohly, W. Gul (2014)
Constituents of Cannabis Sativa
(2015)
J Neuroimmune Pharmacol
I. Galve-Roperh, C. Sánchez, M. Cortés, T. Pulgar, M. Izquierdo, M. Guzmán (2000)
Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activationNature Medicine, 6
R. Mechoulam, S. Ben-Shabat, L. Hanuš, M. Ligumsky, N. Kaminski, A. Schatz, A. Gopher, S. Almog, B. Martin, D. Compton, R. Pertwee, G. Griffin, M. Bayewitch, J. Barg, Z. Vogel (1995)
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.Biochemical pharmacology, 50 1
D. Ryan, Alison Drysdale, C. Lafourcade, R. Pertwee, B. Platt (2009)
Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+ LevelsThe Journal of Neuroscience, 29
Paola Massi, M. Valenti, A. Vaccani, V. Gasperi, G. Perletti, E. Marras, F. Fezza, M. Maccarrone, D. Parolaro (2008)
5‐Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non‐psychoactive cannabinoidJournal of Neurochemistry, 104
Rachel Wilson, R. Nicoll (2002)
Endocannabinoid Signaling in the BrainScience, 296
R. Mckallip, W. Jia, J. Schlomer, J. Warren, P. Nagarkatti, M. Nagarkatti (2006)
Cannabidiol-Induced Apoptosis in Human Leukemia Cells: A Novel Role of Cannabidiol in the Regulation of p22phox and Nox4 ExpressionMolecular Pharmacology, 70
M. Holland, J. Panetta, J. Hoskins, M. Bebawy, B. Roufogalis, J. Allen, J. Arnold (2006)
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.Biochemical pharmacology, 71 8
J. Huffman, Shu Yu, V. Showalter, M. Abood, J. Wiley, D. Compton, B. Martin, R. Bramblett, P. Reggio (1996)
Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor.Journal of medicinal chemistry, 39 20
Zahida Qamri, Anju Preet, M. Nasser, C. Bass, G. Leone, S. Barsky, R. Ganju (2009)
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancerMolecular Cancer Therapeutics, 8
A. Carracedo, M. Lorente, Ainara Egia, C. Blázquez, S. Garcia, V. Giroux, C. Malicet, R. Villuendas, M. Gironella, L. González-Feria, M. Piris, J. Iovanna, M. Guzmán, G. Velasco (2006)
The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells.Cancer cell, 9 4
Nadine Freimuth, R. Ramer, B. Hinz (2010)
Antitumorigenic Effects of Cannabinoids beyond ApoptosisJournal of Pharmacology and Experimental Therapeutics, 332
Eric Singer, Jonathon Judkins, N. Salomonis, Lisa Matlaf, P. Soteropoulos, S. McAllister, L. Soroceanu (2015)
Reactive oxygen species-mediated therapeutic response and resistance in glioblastomaCell Death & Disease, 6
R. Ramer, Anja Rohde, J. Merkord, Helga Rohde, B. Hinz (2010)
Decrease of Plasminogen Activator Inhibitor-1 May Contribute to the Anti-Invasive Action of Cannabidiol on Human Lung Cancer CellsPharmaceutical Research, 27
Mario Perez-Reyes, Mario Perez-Reyes, M. Timmons, M. Timmons, K. Davis, K. Davis, E. Wall, E. Wall (1973)
A comparison of the pharmacological activity in man of intravenously administered 1368-11368-11368-1, cannabinol, and cannabidiolExperientia, 29
A. Ligresti, A. Moriello, K. Starowicz, I. Matias, S. Pisanti, L. Petrocellis, C. Laezza, G. Portella, M. Bifulco, V. Marzo (2006)
Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast CarcinomaJournal of Pharmacology and Experimental Therapeutics, 318
R. Ramer, J. Merkord, Helga Rohde, B. Hinz (2010)
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1.Biochemical pharmacology, 79 7
S. Sarfaraz, V. Adhami, D. Syed, F. Afaq, H. Mukhtar (2008)
Cannabinoids for cancer treatment: progress and promise.Cancer research, 68 2
M. Holland, D. Lau, J. Allen, J. Arnold (2007)
The multidrug transporter ABCG2 (BCRP) is inhibited by plant‐derived cannabinoidsBritish Journal of Pharmacology, 152
R. Pertwee (2006)
Cannabinoid pharmacology: the first 66 yearsBritish Journal of Pharmacology, 147
N. Rimmerman, Danya Ben-Hail, Z. Porat, A. Juknat, E. Kozela, M. Daniels, P. Connelly, E. Leishman, Heather Bradshaw, V. Shoshan-Barmatz, Zvi Vogel (2013)
Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell deathCell Death & Disease, 4
L. Soroceanu, R. Murase, Chandani Limbad, Eric Singer, J. Allison, I. Adrados, Rumi Kawamura, Arash Pakdel, Yayoi Fukuyo, Daniel Nguyen, Sabeena Khan, Robert Arauz, G. Yount, D. Moore, P. Desprez, S. McAllister (2013)
Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target.Cancer research, 73 5
M. Caffarel, C. Andradas, E. Mira, E. Pérez-Gómez, C. Cerutti, G. Moreno-Bueno, J. Flores, I. García-Real, J. Palacios, S. Mañes, M. Guzmán, C. Sánchez (2010)
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibitionMolecular Cancer, 9
K. Brady, R. Balster (1980)
The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys.Psychopharmacology, 72 1
D. Piomelli (2003)
The molecular logic of endocannabinoid signallingNature Reviews Neuroscience, 4
N. Kogan, M. Schlesinger, E. Priel, R. Rabinowitz, E. Berenshtein, M. Chevion, R. Mechoulam (2007)
HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitorMolecular Cancer Therapeutics, 6
Hao Hu, Hui-Ying Han, Yu Wang, Xiao Zhang, C. Chua, Y. Wong, Xiao Wang, M. Ling, Kexin Xu (2009)
The role of Id-1 in chemosensitivity and epirubicin-induced apoptosis in bladder cancer cells.Oncology reports, 21 4
L. Bornheim, M. Grillo (1998)
Characterization of cytochrome P450 3A inactivation by cannabidiol: possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator.Chemical research in toxicology, 11 10
G. Nahas, W. Paton (1978)
Marihuana biological effects. Analysis, metabolism, cellular responses, reproduction and brain. Proceedings of the Satellite Symposium of the 7th Interantional Congress of Pharmacology, Paris, 22--23 July 1978.Advances in the biosciences, 22-23
S. Emery, M. Alotaibi, Q. Tao, D. Selley, A. Lichtman, D. Gewirtz (2014)
Combined Antiproliferative Effects of the Aminoalkylindole WIN55,212-2 and Radiation in Breast Cancer CellsThe Journal of Pharmacology and Experimental Therapeutics, 348
G. Wondrak (2009)
Redox-directed cancer therapeutics: molecular mechanisms and opportunities.Antioxidants & redox signaling, 11 12
M. Srivastava, B. Srivastava, B. Brouhard (1998)
Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells.Immunopharmacology, 40 3
L. Petrocellis, A. Ligresti, A. Moriello, Mariagrazia Iappelli, R. Verde, C. Stott, L. Cristino, P. Orlando, V. Marzo (2013)
Non‐THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro‐apoptotic effects and underlying mechanismsBritish Journal of Pharmacology, 168
H. Edery, Y. Grunfeld, Z. Ben‐Zvi, R. Mechoulam (1971)
STRUCTURAL REQUIREMENTS FOR CANNABINOID ACTIVITY *Annals of the New York Academy of Sciences, 191
M. Salazar, A. Carracedo, Iñigo Salanueva, S. Hernández‐Tiedra, M. Lorente, Ainara Egia, Patricia Vázquez, C. Blázquez, Sofía Torres, S. Garcia, J. Nowak, G. Fimia, M. Piacentini, F. Cecconi, P. Pandolfi, L. González-Feria, J. Iovanna, M. Guzmán, P. Boya, G. Velasco (2009)
Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells.The Journal of clinical investigation, 119 5
J. Guindon, A. Hohmann (2011)
The endocannabinoid system and cancer: therapeutic implicationBritish Journal of Pharmacology, 163
R Karler, SA Turkanis (1979)
Marihuana: biological effects, analysis, metabolism, cellular responses, reproduction and brain
M. Nasser, Zahida Qamri, Y. Deol, Diane Smith, K. Shilo, X. Zou, R. Ganju (2011)
Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB2 in Modulating Breast Cancer Growth and InvasionPLoS ONE, 6
C. Albanese, J. Johnson, G. Watanabe, Nathan Eklund, D. Vu, A. Arnold, R. Pestell (1995)
Transforming p21ras Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions (*)The Journal of Biological Chemistry, 270
M. Srivastava, B. Srivastava, B. Brouhard (1998)
Δ9 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cellsImmunopharmacology, 40
K. Sarker, I. Maruyama (2003)
Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid raftsCellular and Molecular Life Sciences CMLS, 60
P. Massi, Marta Solinas, V. Cinquina, D. Parolaro (2013)
Cannabidiol as potential anticancer drugBritish Journal of Clinical Pharmacology, 75
As a therapeutic agent, most people are familiar with the palliative effects of the primary psychoactive constituent of Cannabis sativa (CS), Δ9-tetrahydrocannabinol (THC), a molecule active at both the cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor subtypes. Through the activation primarily of CB1 receptors in the central nervous system, THC can reduce nausea, emesis and pain in cancer patients undergoing chemotherapy. During the last decade, however, several studies have now shown that CB1 and CB2 receptor agonists can act as direct antitumor agents in a variety of aggressive cancers. In addition to THC, there are many other cannabinoids found in CS, and a majority produces little to no psychoactivity due to the inability to activate cannabinoid receptors. For example, the second most abundant cannabinoid in CS is the non-psychoactive cannabidiol (CBD). Using animal models, CBD has been shown to inhibit the progression of many types of cancer including glioblastoma (GBM), breast, lung, prostate and colon cancer. This review will center on mechanisms by which CBD, and other plant-derived cannabinoids inefficient at activating cannabinoid receptors, inhibit tumor cell viability, invasion, metastasis, angiogenesis, and the stem-like potential of cancer cells. We will also discuss the ability of non-psychoactive cannabinoids to induce autophagy and apoptotic-mediated cancer cell death, and enhance the activity of first-line agents commonly used in cancer treatment.
Journal of Neuroimmune Pharmacology – Springer Journals
Published: Apr 28, 2015
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.